Checkpoint Therapeutics, Inc.: Clinical Trials

4 trials sponsored by Checkpoint Therapeutics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1
Phase 31Terminated 1
Phase 41Recruiting 1

Follow Checkpoint Therapeutics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Cosibelimab, Prednisone, Sirolimus - Cutaneous Squamous Cell Carcinoma, Skin Cancer
Phase 4RecruitingDana-Farber Cancer Institute802026-04-232026-08-11
Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC
Cosibelimab, Cisplatin, Carboplatin - Metastatic Non-squamous Non Small Cell Lung Cancer
Phase 3TerminatedCheckpoint Therapeutics, Inc.252021-12-082025-04-02
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
CK-301 (cosibelimab) - Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase 1Active not recruitingCheckpoint Therapeutics, Inc.2722017-09-202025-02-03
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
CK-101 - Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase 1CompletedCheckpoint Therapeutics, Inc.1362016-09-012022-07-26

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)  ·  Lung Neoplasms (3)  ·  Neoplasms (2)  ·  Skin Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Small Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lung Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)

Interventions

Carboplatin (1)  ·  Cisplatin (1)  ·  Dexamethasone (1)  ·  Everolimus (1)  ·  Folic Acid (1)  ·  Pemetrexed (1)  ·  Prednisone (1)  ·  Sirolimus (1)  ·  Vitamin B 12 (1)

Countries

New Zealand (3)  ·  Thailand (3)  ·  Australia (2)  ·  Poland (2)  ·  Russia (2)  ·  South Africa (2)  ·  United States (2)  ·  Brazil (1)  ·  France (1)  ·  Georgia (1)  ·  Malaysia (1)  ·  Peru (1)  ·  Spain (1)  ·  Ukraine (1)

Top investigators

Ann Silk, MD (1)

Results publications

PMID 37848259